Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Paragon Care Limited ( (AU:PGC) ) has issued an announcement.
Paragon Care Limited has completed the acquisition of the Somnotec Group, excluding its Thailand business, which awaits a foreign business license. The acquisition strengthens Paragon Care’s presence in the Asia Pacific healthcare market, although the pending Thailand acquisition, contributing 17.5% of Somnotec’s EBITDA, is expected to finalize in 6 to 12 months.
The most recent analyst rating on (AU:PGC) stock is a Hold with a A$0.23 price target. To see the full list of analyst forecasts on Paragon Care Limited stock, see the AU:PGC Stock Forecast page.
More about Paragon Care Limited
Paragon Care Limited is an Australian-based company in the healthcare sector, known for providing medical equipment, devices, consumables, pharmaceuticals, complementary medicines, nutritional supplies, and manufacturing Blood Bank diagnostic reagents. It serves healthcare markets in Australia, New Zealand, and Asia.
Average Trading Volume: 773,295
Technical Sentiment Signal: Sell
Current Market Cap: A$438.7M
For a thorough assessment of PGC stock, go to TipRanks’ Stock Analysis page.